Aclaris Therapeutics, Inc. · NASDAQ:ACRS

Kolbeck Roland Wilhelm exercised options for 36,375 Aclaris Therapeutics, Inc. shares (Form 4)

Traded Aug 1, 2026 · Filed Aug 4, 2026

On Aug 1, 2026, Kolbeck Roland Wilhelm (Chief Scientific Officer) exercised options for 36,375 Aclaris Therapeutics, Inc. shares, leaving 23,990 shares. Filed Aug 4, 2026 (Form 4).

Options exercised
36,375 shares
Holding after
23,990 shares
Trading plan
No
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 1, 2026Common StockOption exercise36,37536,375Direct
Aug 1, 2026Common StockShares withheld for tax12,385US$5.2023,990Direct

Source

View original at SEC

Related